April 18th 2025
Using cholesterol-modified oligonucleotides, the research team aims to improve the delivery of antisense nucleotide-based therapies for treating neurodegenerative diseases and brain cancers.
Beyond Dolly - Scotland's Life Sciences Industry Moves into the 21st Century
April 1st 2004Scotland's life sciences community lost an icon this past year with the death of Dolly the Sheep. Cloned by Roslin Institute in 1996, Dolly came to symbolize Scotland's world-leading innovation in the life sciences. However, biotechnology in Scotland goes beyond a cloned sheep.
Quintiles in Edinburgh: An Ideal Environment
April 1st 2004Quintiles Transnational is a global company, headquartered in North Carolina. It employs a global workforce of approximately 16,000 in more than 48 countries. The company helps improve healthcare worldwide by providing a broad range of professional services, information, and partnering solutions to the pharmaceutical, biotechnology, and healthcare industries.
Operations Excellence: BioPharma Consortium Discusses Key Industry Trends
March 1st 2004In early November 2003, Wyeth BioPharma, headquartered in Andover, MA, hosted the quarterly meeting of the BioPharma Operations Excellence Consortium. Approximately 50 people representing over 15 companies attended this first meeting of the consortium's newly established East Coast chapter.
Looking for Clues to a Sustained Biopharm Resurgence? Check Out the Job Picture
February 1st 2004On Wall Street, accurately predicting the future is the Holy Grail. At the end of the day, the traders and investors who come closest to guessing what will happen one hour, one day, or one week down the road are the ones who go home winners.
A Major Force in Biotechnology Sweden
January 1st 2004In September 2003, Sweden's biotechnology sector recorded a striking achievement. Amgen, the world's largest biotechnology company, announced plans to acquire exclusive rights to Biovitrum's small-molecule enzyme inhibitors for the treatment of metabolic diseases.